http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2015500231-A

Outgoing Links

Predicate Object
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2121-00
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D263-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D263-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4178
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4184
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-42
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-421
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4422
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-216
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-44
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-41
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4178
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-41
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-421
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-10
filingDate 2012-11-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2015-01-05-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber JP-2015500231-A
titleOfInvention Pharmaceutical composition for preventing or treating hyperlipidemia
abstract The present invention provides (4S, 5R) -5- [3,5-bis (trifluoromethyl) phenyl] -3-({2- [4-fluoro-2-methoxy-5- (propane-2 -Yl) phenyl] -5- (trifluoromethyl) phenyl} methyl) -4-methyl-1,3-oxazolidine-2-one or a pharmaceutically acceptable salt thereof and an angiotensin II receptor blocker A pharmaceutical composition for preventing or treating hyperlipidemia is provided.
priorityDate 2011-11-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419503925
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419503865
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID158781
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID65999
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11556427
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419571304
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3961
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415828206
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419530399
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419504262
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID60846
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID130881

Total number of triples: 45.